News

Supply chain company Owens & Minor released its right to sue over the BlueCard Program by participating in a $2.7 billion ...
Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health (ELV) and its ...
The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.
Elevance Health posted first quarter results Tuesday that beat analyst expectations, with the Indianapolis-based health ...
Glen Tullman, the CEO of Transcarent, is taking another big shot at transforming the U.S. health care system.
Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...
FDA-cleared CureSightâ„¢ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...